FIBROTIC VENTURES
Fibrotic Ventures is an investment firm based in Atlanta, Georgia.
Similar Organizations
First Fractional Funding
First Fractional Funding is an investment firm based in Greenwood Village, Colorado.
Gerdes Huff Investments
Gerdes Huff Investments is a private equity firm based in Atlanta, Georgia.
Nonami Investments
Nonami Investments is private owned investment firm based in Atlanta, Georgia.
Ordinance Capital L.P
Ordinance Capital is an investment firm based in Lantana, Florida.
Red Maple Ventures
Red Maple Ventures is an investment firm based in Wynne, Arkansas.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2012-10-15 | Promedior | Fibrotic Ventures investment in Series D - Promedior | 3 M USD |
| 2012-03-07 | Promedior | Fibrotic Ventures investment in Series D - Promedior | 21.5 M USD |
More informations about "Fibrotic Ventures"
Fibrotic Ventures - Crunchbase Investor Profile & Investments
Fibrotic Ventures is an investment firm based in Atlanta, Georgia. Atlanta, Georgia, United States; Venture Capital Late Stage Venture 145,729See details»
Fibrotic Ventures - Investments, Portfolio & Company Exits
Oct 15, 2012 Fibrotic Ventures is an investment firm based in Atlanta, Georgia. Start Free TrialSee details»
Fibrotic Ventures - CB Insights
Nov 15, 2019 Fibrotic Ventures provides consulting and management of investment vehicles and investments. Headquarters Location. 200 Ashford Center North Suite 210. Atlanta, Georgia, …See details»
Fibrotic Ventures — 2 Investments, Performance analytics, Stats ...
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Fibrotic Ventures, startups are often financed by Forbion Capital Partners. The meaningful sponsors for the fund …See details»
Series D - Promedior - 2012-03-07 - Crunchbase
Mar 7, 2012 Fibrotic Ventures Fibrotic Ventures is an investment firm based in Atlanta, Georgia. Investors. Edit Investors Section. Number of Investors 6. Number of Partner Investors 4. …See details»
Venture partners create fibrosis-focused therapeutics company
Dec 16, 2024 Venture studios Deep Science Ventures and General Inception have announced plans to create a company focused on developing novel treatments for fibrosis. Science …See details»
The $3.3 Billion Case for Venture Philanthropy
Dec 4, 2014 Recently, the Cystic Fibrosis Foundation (CFF) received a record-breaking $3.3 billion return on its $150 million investment in Vertex Pharmaceuticals and a smaller business …See details»
TIAP Features: Fibrocor Therapeutics — Getting to the Core of …
In diseases of fibrosis, excessive scar tissue formation disrupts normal organ function leading to impairment and eventually failure. Recognizing the severity and unmet need, Fibrocor …See details»
Deep Science Ventures and General Inception collaborate to …
12 December 2024 – London, UK, and Palo Alto, CA, US – Deep Science Ventures, a UK-based venture studio, and General Inception, a US-based venture studio, today announced a …See details»
New Funding Rounds in fibrotic disorders - VentureRadar
Search exact phrase instead: "fibrotic disorders" Export + Follow this deals list Following Rubedo Life Sciences, Inc. Venture-funding News ... Rubedo Life Sciences Closes $40M Series A …See details»
Top Fibrotic Disease start-ups - VentureRadar
Mediar Therapeutics. Private Company. Founded 2019. USA. Developing monoclonal antibodies for patients with fibrotic diseases. Mediar Therapeutics is a preclinical stage biotechnology …See details»
Catalysis - Mass General Brigham
Cells. By blocking fibrotic mediators, the progression of fibrosis can be arrested and potentially reversed. With the guidance and insight from the scientific founders, Meredith led the seed …See details»
Fibrotic Ventures - Crunchbase
Fibrotic Ventures . Connect to CRM . Save . Summary Investments People Signals & News Similar Companies. Similar Companies. Edit Similar Companies Section. Companies like …See details»
VCU researchers explore a promising pathway to treating fibrosis
Jun 18, 2024 Their work is also supported by Freeberg’s Pulmonary Fibrosis Scholars grant and a Parker B. Francis Fellowship . After disclosing their technology to VCU TechTransfer and …See details»
HAYA Therapeutics | HAYA Therapeutics Completes CHF 18 Million …
Broadview Ventures is a life science venture fund whose mission is to improve human health in the areas of cardiovascular disease and stroke by investing in early stage companies …See details»
Deep Science Ventures and General Inception collaborate to …
Dec 12, 2024 Deep Science Ventures, a UK-based venture studio, and General Inception, a US-based venture studio, today announced a collaboration to create a company focused on …See details»
Fibrotic | Yale Ventures
Endothelial-Cell Specific Wnt Inhibition: Novel Therapy for Renal Fibrosis Thyron Pharmaceuticals: Thyroid Hormone Mimetics for Reversal of Lung Injury and Fibrosis …See details»
Top Fibrosis start-ups - VentureRadar
180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging …See details»
Fibrocor Therapeutics Started in Canada to Treat Fibrotic Diseases …
Jan 25, 2017 “Through Fibrocor we have created a transformational partnership with Evotec to translate Toronto’s world-class fibrosis expertise into therapies for patients worldwide,” Rafi …See details»
Explore Healthcare Innovation Insights: The Magnetic Ventures Blog
Dive into the minds of industry leaders at Magnetic Ventures. Read our blog for in-depth insights on healthcare innovation, technology, and team strategies. Stay informed, stay inspired. Start …See details»